Korea Arlico Pharm Co.,Ltd. is based in South Korea. The head office is in Seoul. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on October 01, 1992. It currently has a total number of 228 (2025) employees. The company’s latest financial report indicates a net sales revenue increase of 5.65% in 2025. There was a total negative growth of 0.3% in Korea Arlico Pharm Co.,Ltd.’s total assets over the same period. In, 2025, the company’s net profit margin increased by 2.51%.

Headquarters
Korea Arlico Pharm Bildg, 7-21, Baumoe-Ro 27-Gil, Seocho-Gu
Seoul; Seoul;

Contact Details: Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.

Website: http://www.arlico.co.kr/

Basic Information

Total Employees:

Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.

Outstanding Shares:

Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.

Registered Capital:

Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.

Financial Auditors:

Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.

Incorporation Date:

October 01, 1992

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

41%

Purchase this report to view the information.

6.3%

Purchase this report to view the information.

2.6%

Company Performance

Financial values in the chart are available after Korea Arlico Pharm Co.,Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

5.65%▲

Total Operating Revenue

5.42%▲

Operating Profit

N/A

EBITDA

196.03%▲

Net Profit/Loss for the Period

88.7%▲

Total Assets

-0.3%▼

Total Equity

-1.85%▼

Operating Profit Margin

N/A

Net Profit Margin

2.51%▲

Return on Equity (ROE)

5.95%▲

Debt / Equity

-0.61%▼

Quick Ratio

-0.02%▼

Cash Ratio

0.05%▲

Korea Arlico Pharm Co.,Ltd. (South Korea)

Similar companies